Skip to main content
Caplight Logo









MicroQuin

MicroQuin

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.microquin.com/

Last Round

Grant

Feb 1, 2025

Company Overview

MicroQuin is a biotechnology company developing therapeutics that modulate the intracellular environment to treat cancer, neurodegenerative disorders, and viral infections.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Application

Keywords

small molecule drugsoncology therapeuticsdrug discoveryintracellular environment modulationpreclinical biotechsolid tumor treatmentAI drug discoverypharma partnershipsAI biotechneurodegenerative disease treatmentviral disease treatmentCongressionally Directed Medical Research ProgramsCDMRP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MicroQuin Comparables

Compare MicroQuin with similar companies based on industry and business-model similarity.

MicroQuin comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EtiraRx
82%
Celloram Inc.
78%
Aprea Therapeutics
72%

MicroQuin Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2025
GrantOct 18, 2018
AcceleratorMay 23, 2018

MicroQuin Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2025

    Received funding from Congressionally Directed Medical Research Programs.

  • Oct 18, 2018

    Received grant funding from Boeing and CASIS.

MicroQuin Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MicroQuin Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MicroQuin's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range3
Year Founded2016
Last FundingFeb 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?